Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteers.

× No keyword cloud information.

5 in total

1. Antifibrinolytic therapy with Cyklokapron in connection with prostatectomy. A double blind study.

Authors: P O Hedlund
Journal: Scand J Urol Nephrol Date: 1969

2. Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.

Authors: S Riegelman; J C Loo; M Rowland
Journal: J Pharm Sci Date: 1968-01 Impact factor: 3.534

3. Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA.

Authors: L Andersson; I M Nilsoon; S Colleen; B Granstrand; B Melander
Journal: Ann N Y Acad Sci Date: 1968-06-28 Impact factor: 5.691

4. AMCA (aminomethyl cyclohexane carboxylic acid, Cyklo-kapron) a potent haemostatic agent in urinary tract bleeding.

Authors: L Andersson; I M Nilsson
Journal: Scand J Urol Nephrol Date: 1969

5. [Intestinal absorption, distribution and elimination of 4-aminomethylcyclohexanecarboxylic acid (AMCHA) and epsilon-aminocaproic acid (ACA) in humans].

Authors: H Kaller
Journal: Naunyn Schmiedebergs Arch Exp Pathol Pharmakol Date: 1967

5 in total

40 in total

1. Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.

Authors: Keerati Charoencholvanich; Pichet Siriwattanasakul
Journal: Clin Orthop Relat Res Date: 2011-04-22 Impact factor: 4.176

2. Effect of tranexamic acid on blood loss reduction after cardiopulmonary bypass.

Authors: Y Uozaki; G Watanabe; K Kotou; K Ueyama; Y Doi; T Misaki
Journal: Jpn J Thorac Cardiovasc Surg Date: 2001-05

3. Efficacy of Tranexamic Acid in Reducing Blood Loss during Maxillofacial Trauma Surgery-A Pilot Study.

Authors: Abu Dakir; Balakrishnan Ramalingam; Vijay Ebenezer; Prakash Dhanavelu
Journal: J Clin Diagn Res Date: 2014-05-15

4. The antifibrinolytic drug tranexamic acid reduces liver injury and fibrosis in a mouse model of chronic bile duct injury.

Authors: Nikita Joshi; Anna K Kopec; Keara Towery; Kurt J Williams; James P Luyendyk
Journal: J Pharmacol Exp Ther Date: 2014-03-14 Impact factor: 4.030

5. Less blood loss under concomitant administration of tranexamic acid and indirect factor Xa inhibitor following total knee arthroplasty: a prospective randomized controlled trial.

Authors: Sang Hak Lee; Kye-Youl Cho; Sumit Khurana; Kang-Il Kim
Journal: Knee Surg Sports Traumatol Arthrosc Date: 2012-10-02 Impact factor: 4.342

Review 6. Antifibrinolytic Therapy and Perioperative Considerations.

Authors: Jerrold H Levy; Andreas Koster; Quintin J Quinones; Truman J Milling; Nigel S Key
Journal: Anesthesiology Date: 2018-03 Impact factor: 7.892

7. Pharmacokinetic data. Pharmacokinetic parameters estimated from intravenous data by uniform methods and some of their uses.

Authors: J G Wagner
Journal: J Pharmacokinet Biopharm Date: 1977-04

Review 8. Clinical pharmacology of aminocaproic and tranexamic acids.

Authors: I M Nilsson
Journal: J Clin Pathol Suppl (R Coll Pathol) Date: 1980

9. A Fibrin Cross-linking Polymer Enhances Clot Formation Similar to Factor Concentrates and Tranexamic Acid in an in vitro Model of Coagulopathy.

Authors: Leslie W Chan; Nathan J White; Suzie H Pun
Journal: ACS Biomater Sci Eng Date: 2016-01-28

10. Population pharmacokinetics of tranexamic acid in paediatric patients undergoing craniosynostosis surgery.

Authors: Susan M Goobie; Petra M Meier; Navil F Sethna; Sulpicio G Soriano; David Zurakowski; Snehal Samant; Luis M Pereira
Journal: Clin Pharmacokinet Date: 2013-04 Impact factor: 6.447